By Rafael Müller
Publication Date: 2026-10-15 09:04:00
IBM (ISIN US4592001014) was trading at EUR 203.80 at Lang & Schwarz on October 15, 2026 at 11:00 a.m. CEST, 1.88 percent below the Xetra close of October 14, 2026 at EUR 207.70. According to Investing.com on October 13, 2026, UBS reiterated a Neutral rating and a USD 236.00 price target for IBM. The assessment puts execution and delayed deals ahead of the company’s quantum-computing ambitions.
Three events shape the story
On July 22, 2026, IBM reported second-quarter revenue of USD 17.16 billion, up 1.10 percent from the prior year, while adjusted earnings per share reached USD 2.93 against consensus of USD 2.93, according to MarketBeat. On October 7, 2026, IBM announced selection for Stage C of the DARPA Quantum Benchmarking Initiative, with the company expecting its first fault-tolerant system in 2029, according to IBM. On October 13, 2026, UBS maintained its USD 236.00 target, according to Investing.com.
What does the target imply?
UBS cited limited recovery of delayed contracts…
